{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T16:59:08Z","timestamp":1790787548991,"version":"4.1.0"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001332","name":"CSIR","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100001332","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cytokine"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1016\/j.cyto.2020.155301","type":"journal-article","created":{"date-parts":[[2020,10,28]],"date-time":"2020-10-28T03:04:49Z","timestamp":1603854289000},"page":"155301","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"special_numbering":"C","title":["Oral administration of eugenol oleate cures experimental visceral leishmaniasis through cytokines abundance"],"prefix":"10.1016","volume":"145","author":[{"given":"Mamilla R.","family":"Charan Raja","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amrita","family":"Kar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sujatha","family":"Srinivasan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Davidraj","family":"Chellappan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4811-5996","authenticated-orcid":false,"given":"Joy","family":"Debnath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Santanu","family":"Kar Mahapatra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cyto.2020.155301_b0005","unstructured":"WHO, Epidemiological situation, 2020."},{"issue":"5","key":"10.1016\/j.cyto.2020.155301_b0010","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0035671","article-title":"Leishmaniasis worldwide and global estimates of its incidence","volume":"7","author":"Alvar","year":"2012","journal-title":"PLoS One"},{"issue":"11","key":"10.1016\/j.cyto.2020.155301_b0015","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1038\/nrmicro1748","article-title":"Visceral leishmaniasis: what are the needs for diagnosis, treatment and control?","volume":"5","author":"Chappuis","year":"2007","journal-title":"Nat. Rev. Microbiol."},{"issue":"3","key":"10.1016\/j.cyto.2020.155301_b0020","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1517\/14728210903153862","article-title":"Developments in the treatment of visceral leishmaniasis","volume":"14","author":"den Boer","year":"2009","journal-title":"Expert Opin. Emerging Drugs"},{"issue":"1","key":"10.1016\/j.cyto.2020.155301_b0025","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1517\/14656566.2013.755515","article-title":"Leishmaniasis: an update of current pharmacotherapy","volume":"14","author":"Sundar","year":"2013","journal-title":"Expert Opin. Pharmacother."},{"key":"10.1016\/j.cyto.2020.155301_b0030","doi-asserted-by":"crossref","unstructured":"K. Ritmeijer, R.N. Davidson, Royal Society of Tropical Medicine and Hygiene joint meeting with Medecins Sans Frontieres at Manson House, London, 20 March 2003: field research in humanitarian medical programmes. Medecins Sans Frontieres interventions against kala-azar in the Sudan, 1989-2003, Trans. R Soc. Trop. Med. Hyg. 97(6) (2003) 609-13.","DOI":"10.1016\/S0035-9203(03)80047-0"},{"issue":"1","key":"10.1016\/j.cyto.2020.155301_b0035","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.trstmh.2006.02.005","article-title":"Unresponsiveness to Am Bisome in some Sudanese patients with kala-azar","volume":"101","author":"Mueller","year":"2007","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"issue":"22","key":"10.1016\/j.cyto.2020.155301_b0040","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1056\/NEJMoa021556","article-title":"Oral miltefosine for Indian visceral leishmaniasis","volume":"347","author":"Sundar","year":"2002","journal-title":"N. Engl. J. Med."},{"issue":"24","key":"10.1016\/j.cyto.2020.155301_b0045","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1056\/NEJM199912093412403","article-title":"Miltefosine, an oral agent, for the treatment of Indian visceral leishmaniasis","volume":"341","author":"Jha","year":"1999","journal-title":"N. Engl. J. Med."},{"issue":"5","key":"10.1016\/j.cyto.2020.155301_b0050","first-page":"733","article-title":"Miltefosine in the treatment of leishmaniasis: clinical evidence for informed clinical risk management","volume":"3","author":"Sundar","year":"2007","journal-title":"Ther. Clin. Risk Manag."},{"key":"10.1016\/j.cyto.2020.155301_b0055","doi-asserted-by":"crossref","unstructured":"K. Rai, B. Cuypers, N.R. Bhattarai, S. Uranw, M. Berg, B. Ostyn, J.C. Dujardin, S. Rijal, M. Vanaerschot, Relapse after treatment with miltefosine for visceral leishmaniasis is associated with increased infectivity of the infecting Leishmania donovani strain, mBio 4(5) (2013) e00611-13.","DOI":"10.1128\/mBio.00611-13"},{"issue":"4","key":"10.1016\/j.cyto.2020.155301_b0060","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1093\/cid\/cis474","article-title":"Efficacy of miltefosine in the treatment of visceral leishmaniasis in India after a decade of use","volume":"55","author":"Sundar","year":"2012","journal-title":"Clin. Infect. Dis."},{"issue":"15","key":"10.1016\/j.cyto.2020.155301_b0065","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1016\/j.micinf.2012.05.014","article-title":"Leishmania virulence factors: focus on the metalloprotease GP63","volume":"14","author":"Olivier","year":"2012","journal-title":"Microbes Infect."},{"issue":"1\u20132","key":"10.1016\/j.cyto.2020.155301_b0070","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1023\/A:1011048210691","article-title":"Selective impairment of protein kinase C isotypes in murine macrophage by Leishmania donovani","volume":"216","author":"Bhattacharyya","year":"2001","journal-title":"Mol. Cell. Biochem."},{"issue":"1\u20132","key":"10.1016\/j.cyto.2020.155301_b0075","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1023\/A:1017996609928","article-title":"Generation of ceramide in murine macrophages infected with Leishmania donovani alters macrophage signaling events and aids intracellular parasitic survival","volume":"223","author":"Ghosh","year":"2001","journal-title":"Mol. Cell. Biochem."},{"issue":"3","key":"10.1016\/j.cyto.2020.155301_b0080","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1128\/IAI.69.3.1499-1507.2001","article-title":"Immunomodulatory role of interleukin-10 in visceral leishmaniasis: defective activation of protein kinase C-mediated signal transduction events","volume":"69","author":"Bhattacharyya","year":"2001","journal-title":"Infect. Immun."},{"issue":"8","key":"10.1016\/j.cyto.2020.155301_b0085","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1006\/cyto.2000.0694","article-title":"IL-10 and IL-12 are the main regulatory cytokines in visceral leishmaniasis","volume":"12","author":"Bacellar","year":"2000","journal-title":"Cytokine"},{"key":"10.1016\/j.cyto.2020.155301_b0090","doi-asserted-by":"crossref","unstructured":"F.Y. Liew, S. Millott, C. Parkinson, R.M. Palmer, S. Moncada, Macrophage killing of Leishmania parasite in vivo is mediated by nitric oxide from L-arginine, Journal of immunology (Baltimore, Md.: 1950) 144(12) (1990) 4794-7.","DOI":"10.4049\/jimmunol.144.12.4794"},{"issue":"9","key":"10.1016\/j.cyto.2020.155301_b0095","doi-asserted-by":"crossref","first-page":"5026","DOI":"10.1128\/IAI.70.9.5026-5035.2002","article-title":"Activation of p38 mitogen-activated protein kinase attenuates Leishmania donovani infection in macrophages","volume":"70","author":"Junghae","year":"2002","journal-title":"Infect. Immun."},{"key":"10.1016\/j.cyto.2020.155301_b0100","doi-asserted-by":"crossref","unstructured":"T. Ueda-Nakamura, R.R. Mendonca-Filho, J.A. Morgado-Diaz, P. Korehisa Maza, B. Prado Dias Filho, D. Aparicio Garcia Cortez, D.S. Alviano, S. Rosa Mdo, A.H. Lopes, C.S. Alviano, C.V. Nakamura, Antileishmanial activity of Eugenol-rich essential oil from Ocimum gratissimum, Parasitol. Int. 55(2) (2006) 99-105.","DOI":"10.1016\/j.parint.2005.10.006"},{"issue":"Pt 8","key":"10.1016\/j.cyto.2020.155301_b0105","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1099\/jmm.0.009290-0","article-title":"Pro-apoptotic effect of the landrace Bangla Mahoba of Piper betle on Leishmania donovani may be due to the high content of eugenol","volume":"58","author":"Misra","year":"2009","journal-title":"J. Med. Microbiol."},{"key":"10.1016\/j.cyto.2020.155301_b0110","doi-asserted-by":"crossref","unstructured":"S.M. de Morais, N.S. Vila-Nova, C.M.L. Bevilaqua, F.C. Rondon, C.H. Lobo, A. de Alencar Araripe Noronha Moura, A.D. Sales, A.P.R. Rodrigues, J.R. de Figuereido, C.C. Campello, M.E. Wilson, H.F. de Andrade, Jr., Thymol and eugenol derivatives as potential antileishmanial agents, Bioorg. Med. Chem. 22(21) (2014) 6250-6255.","DOI":"10.1016\/j.bmc.2014.08.020"},{"key":"10.1016\/j.cyto.2020.155301_b0115","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.ejmech.2017.08.030","article-title":"Eugenol derived immunomodulatory molecules against visceral leishmaniasis","volume":"139","author":"Charan Raja","year":"2017","journal-title":"Eur. J. Med. Chem."},{"issue":"4","key":"10.1016\/j.cyto.2020.155301_b0120","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/S1461-5347(00)00247-9","article-title":"Recent technological advances in oral drug delivery \u2013 a review","volume":"3","author":"Sastry","year":"2000","journal-title":"Pharm. Sci. Technol. Today"},{"key":"10.1016\/j.cyto.2020.155301_b0125","unstructured":"Target Product Profiles (TPP). https:\/\/www.dndi.org\/diseases-projects\/target-product-profiles\/."},{"key":"10.1016\/j.cyto.2020.155301_b0130","unstructured":"OECD, Test No. 423: Acute Oral toxicity, Acute Toxic Class Method, OECD Guidelines for the Testing of Chemicals, OECD Publishing, Paris."},{"key":"10.1016\/j.cyto.2020.155301_b0135","doi-asserted-by":"crossref","unstructured":"P. Wadhone, M. Maiti, R. Agarwal, V. Kamat, S. Martin, B. Saha, Miltefosine promotes IFN-gamma-dominated anti-leishmanial immune response, J. Immunol. (Baltimore, Md. : 1950) 182(11) (2009) 7146-54.","DOI":"10.4049\/jimmunol.0803859"},{"issue":"4","key":"10.1016\/j.cyto.2020.155301_b0140","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.intimp.2010.12.020","article-title":"Alteration of immune functions and Th1\/Th2 cytokine balance in nicotine-induced murine macrophages: immunomodulatory role of eugenol and N-acetylcysteine","volume":"11","author":"Kar Mahapatra","year":"2011","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.cyto.2020.155301_b0145","doi-asserted-by":"crossref","unstructured":"M. Munder, K. Eichmann, M. Modolell, Alternative metabolic states in murine macrophages reflected by the nitric oxide synthase\/arginase balance: competitive regulation by CD4+ T cells correlates with Th1\/Th2 phenotype, J. Immunol. (Baltimore, Md. : 1950) 160(11) (1998) 5347-54.","DOI":"10.4049\/jimmunol.160.11.5347"},{"issue":"10","key":"10.1016\/j.cyto.2020.155301_b0150","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1021\/acsinfecdis.5b00081","article-title":"A Novel Sterol Isolated from a Plant Used by Mayan Traditional Healers Is Effective in Treatment of Visceral Leishmaniasis Caused by Leishmania donovani","volume":"1","author":"Gupta","year":"2015","journal-title":"ACS Infect. Dis."},{"issue":"66","key":"10.1016\/j.cyto.2020.155301_b0155","first-page":"61777","article-title":"Acetyl shikonin induces IL-12, nitric oxide and ROS to kill intracellular parasite Leishmania donovani in infected hosts, RSC","volume":"6","author":"Charan Raja","year":"2016","journal-title":"Advances"},{"issue":"12","key":"10.1016\/j.cyto.2020.155301_b0160","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1093\/carcin\/bgr208","article-title":"TLR signaling-mediated differential histone modification at IL-10 and IL-12 promoter region leads to functional impairments in tumor-associated macrophages","volume":"32","author":"Banerjee","year":"2011","journal-title":"Carcinogenesis"},{"issue":"8","key":"10.1016\/j.cyto.2020.155301_b0165","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1086\/605895","article-title":"CXC chemokine-mediated protection against visceral leishmaniasis: involvement of the proinflammatory response","volume":"200","author":"Gupta","year":"2009","journal-title":"J. Infect. Dis."},{"issue":"2","key":"10.1016\/j.cyto.2020.155301_b0170","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1080\/15376510802255184","article-title":"In vitro nicotine-induced oxidative stress in mice peritoneal macrophages: a dose-dependent approach","volume":"19","author":"Mahapatra","year":"2009","journal-title":"Toxicol. Mech. Methods"},{"issue":"12","key":"10.1016\/j.cyto.2020.155301_b0175","doi-asserted-by":"crossref","first-page":"2892","DOI":"10.1093\/jac\/dks315","article-title":"Mycobacterium indicus pranii (Mw)-mediated protection against visceral leishmaniasis: involvement of TLR4 signalling","volume":"67","author":"Adhikari","year":"2012","journal-title":"J. Antimicrobial Chemotherapy"},{"issue":"11","key":"10.1016\/j.cyto.2020.155301_b0180","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.4155\/fmc.14.76","article-title":"The role of pharmacokinetic studies in drug discovery: where are we now, how did we get here and where are we going?","volume":"6","author":"Webborn","year":"2014","journal-title":"Future Med. Chem."},{"key":"10.1016\/j.cyto.2020.155301_b0185","doi-asserted-by":"crossref","unstructured":"S.B. Chauhan, R. Faleiro, R. Kumar, S. Ng, B. Singh, O.P. Singh, S.S. Singh, F. Amante, F.d.L. Rivera, M. Rai, J. Chakravarty, D. Sacks, S. Nylen, S. Sundar, C. Engwerda, Interleukin 2 is an Upstream Regulator of CD4+ T Cells From Visceral Leishmaniasis Patients With Therapeutic Potential, J. Infect. Diseases 220(1) (2019) 163-173.","DOI":"10.1093\/infdis\/jiz074"},{"issue":"2","key":"10.1016\/j.cyto.2020.155301_b0190","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1128\/CMR.18.2.293-305.2005","article-title":"Subversion mechanisms by Which <em>Leishmania<\/em> parasites can escape the host immune response: a signaling point of view","volume":"18","author":"Olivier","year":"2005","journal-title":"Clin. Microbiol. Rev."},{"issue":"12","key":"10.1016\/j.cyto.2020.155301_b0195","doi-asserted-by":"crossref","DOI":"10.3390\/nu9121367","article-title":"The dual antioxidant\/prooxidant effect of eugenol and its action in cancer development and treatment","volume":"9","author":"Bezerra","year":"2017","journal-title":"Nutrients"},{"issue":"10","key":"10.1016\/j.cyto.2020.155301_b0200","doi-asserted-by":"crossref","first-page":"e0005011","DOI":"10.1371\/journal.pntd.0005011","article-title":"Immunotherapeutic potential of eugenol emulsion in experimental visceral leishmaniasis","volume":"10","author":"Islamuddin","year":"2016","journal-title":"PLoS Negl. Trop. Dis."},{"issue":"2","key":"10.1016\/j.cyto.2020.155301_b0205","first-page":"222","article-title":"Pathologic changes in murine leishmaniasis (Leishmania donovani) with special reference to the dynamics of granuloma formation in the liver","volume":"114","author":"Gutierrez","year":"1984","journal-title":"Am. J. Pathol."},{"issue":"3","key":"10.1016\/j.cyto.2020.155301_b0210","doi-asserted-by":"crossref","first-page":"e0007235","DOI":"10.1371\/journal.pntd.0007235","article-title":"Oral activity of the antimalarial endoperoxide 6-(1,2,6,7-tetraoxaspiro[7.11]nonadec-4-yl)hexan-1-ol (N-251) against Leishmania donovani complex","volume":"13","author":"Kwofie","year":"2019","journal-title":"PLoS Negl. Trop. Dis."},{"issue":"4","key":"10.1016\/j.cyto.2020.155301_b0215","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1086\/314659","volume":"179","author":"Ajizian","year":"1999","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.cyto.2020.155301_b0220","doi-asserted-by":"crossref","unstructured":"R. Sudan, N. Srivastava, S.P. Pandey, S. Majumdar, B. Saha, Reciprocal regulation of protein kinase C isoforms results in differential cellular responsiveness, Journal of immunology (Baltimore, Md. : 1950) 188(5) (2012) 2328-37.","DOI":"10.4049\/jimmunol.1101678"},{"issue":"3","key":"10.1016\/j.cyto.2020.155301_b0225","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1111\/j.1349-7006.2007.00702.x","article-title":"Involvement of protein kinase C beta-extracellular signal-regulating kinase 1\/2\/p38 mitogen-activated protein kinase-heat shock protein 27 activation in hepatocellular carcinoma cell motility and invasion","volume":"99","author":"Guo","year":"2008","journal-title":"Cancer Sci."},{"issue":"3","key":"10.1016\/j.cyto.2020.155301_b0230","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1038\/cmi.2013.68","article-title":"The curative effect of fucoidan on visceral leishmaniasis is mediated by activation of MAP kinases through specific protein kinase C isoforms","volume":"11","author":"Sharma","year":"2014","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.cyto.2020.155301_b0235","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1093\/bmb\/ldl003","article-title":"Current understandings on the immunology of leishmaniasis and recent developments in prevention and treatment","volume":"75\u201376","author":"Roberts","year":"2005","journal-title":"Br. Med. Bull."}],"container-title":["Cytokine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466620303173?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466620303173?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T21:00:18Z","timestamp":1760907618000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043466620303173"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9]]},"references-count":47,"alternative-id":["S1043466620303173"],"URL":"https:\/\/doi.org\/10.1016\/j.cyto.2020.155301","relation":{},"ISSN":["1043-4666"],"issn-type":[{"value":"1043-4666","type":"print"}],"subject":[],"published":{"date-parts":[[2021,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Oral administration of eugenol oleate cures experimental visceral leishmaniasis through cytokines abundance","name":"articletitle","label":"Article Title"},{"value":"Cytokine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cyto.2020.155301","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"155301"}}